<DOC>
	<DOC>NCT00788710</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of etoricoxib compared to placebo in the treatment of postoperative pain associated with total abdominal hysterectomy.</brief_summary>
	<brief_title>A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>Patients 18 years or older in generally good health who are scheduled to have a total hysterectomy and who are willing to limit alcohol consumption Patient is allergic to the study drug, other cyclooxygenase2 (COX2) inhibitors/nonsteroidal antiinflammatory drugs (NSAIDS), ibuprofen, morphine, or oxycodone or has hypersensitivity to aspirin or other NSAIDS Patient has uncontrolled high blood pressure Patient has a history of drug and/or alcohol abuse within the last 5 years Patient has taken part in another investigational study within 4 weeks of the start of study Patient is breastfeeding Patient has an active ulcer or inflammatory bowel disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>